Literature DB >> 12171574

Mapping of the benzodiazepine recognition site on GABA(A) receptors.

Erwin Sigel1.   

Abstract

Ligands of the benzodiazepine binding site of the GABAA receptor come in three flavors: positive allosteric modulators, negative allosteric modulators and antagonists, all of which can bind with high affinity. The GABA(A) receptor is a pentameric protein which forms a chloride selective ion channel and ligands of the benzodiazepine binding site stabilize three different conformations of this receptor channel. Classical benzodiazepines exert a positive allosteric effect by increasing the affinity of channel opening by the agonist gamma-aminobutyric acid (GABA). We concentrate here on the major adult isoform, the alpha1beta2gamma2 GABA(A) receptor. The binding pocket for benzodiazepines is located in a subunit cleft between gamma2 and alpha1 subunits in a position homologous to the agonist binding site for GABA that is located between alpha1 and beta2 subunits. It is reviewed here how we arrived at this picture. In particular, point mutations were performed in combination with subsequent analysis of the expressed mutant proteins using either electrophysiological techniques or radioactive ligand binding assays. The predictive power of these methods is assessed by comparing the results with the predictions that can be made on the basis of the recently published crystal structure of the acetylcholine binding protein that shows homology to the N-terminal, extracellular domain of the GABA(A) receptor.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12171574     DOI: 10.2174/1568026023393444

Source DB:  PubMed          Journal:  Curr Top Med Chem        ISSN: 1568-0266            Impact factor:   3.295


  74 in total

Review 1.  Pharmacology of P2X channels.

Authors:  Joel R Gever; Debra A Cockayne; Michael P Dillon; Geoffrey Burnstock; Anthony P D W Ford
Journal:  Pflugers Arch       Date:  2006-04-29       Impact factor: 3.657

2.  Picrotoxin-like channel blockers of GABAA receptors.

Authors:  Richard W Olsen
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-10       Impact factor: 11.205

3.  Gender and age differences in expression of GABAA receptor subunits in rat somatosensory thalamus and cortex in an absence epilepsy model.

Authors:  Huifang Li; John R Huguenard; Robert S Fisher
Journal:  Neurobiol Dis       Date:  2007-01-05       Impact factor: 5.996

4.  Allosteric modulators induce distinct movements at the GABA-binding site interface of the GABA-A receptor.

Authors:  Feyza Sancar; Cynthia Czajkowski
Journal:  Neuropharmacology       Date:  2010-11-18       Impact factor: 5.250

Review 5.  Mechanisms of drug combinations: interaction and network perspectives.

Authors:  Jia Jia; Feng Zhu; Xiaohua Ma; Zhiwei Cao; Zhiwei W Cao; Yixue Li; Yixue X Li; Yu Zong Chen
Journal:  Nat Rev Drug Discov       Date:  2009-02       Impact factor: 84.694

Review 6.  GABAA receptors, anesthetics and anticonvulsants in brain development.

Authors:  Oliver Henschel; Keith E Gipson; Angelique Bordey
Journal:  CNS Neurol Disord Drug Targets       Date:  2008-04       Impact factor: 4.388

7.  Agonist-specific conformational changes in the α1-γ2 subunit interface of the GABA A receptor.

Authors:  Megan M Eaton; You Bin Lim; John Bracamontes; Joe Henry Steinbach; Gustav Akk
Journal:  Mol Pharmacol       Date:  2012-05-09       Impact factor: 4.436

8.  The chemistry and pharmacology of privileged pyrroloquinazolines.

Authors:  Bo Chao; Bingbing X Li; Xiangshu Xiao
Journal:  Medchemcomm       Date:  2015-04-01       Impact factor: 3.597

Review 9.  GABAA receptor: Positive and negative allosteric modulators.

Authors:  Richard W Olsen
Journal:  Neuropharmacology       Date:  2018-01-31       Impact factor: 5.250

10.  Colchicine: a novel positive allosteric modulator of the human 5-hydroxytryptamine3A receptor.

Authors:  A N de Oliveira-Pierce; R Zhang; T K Machu
Journal:  J Pharmacol Exp Ther       Date:  2009-02-02       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.